Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in perioperative cardiac protection for heart valve replacement
ChiCTR1800015524Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in Cardiac valve disease (VHD) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Echocardiography, Serum creatine kinase and 4 more. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR1800015524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015524.